Keyphrases
Cardiomyopathy
92%
Hypertrophic Cardiomyopathy
71%
Catecholaminergic Polymorphic Ventricular Tachycardia
62%
Latent Inhibition
52%
Arrhythmia
45%
Schizophrenia
41%
Dilated Cardiomyopathy
41%
AMP-activated Protein Kinase
40%
Human Induced Pluripotent Stem Cell-derived Cardiomyocytes (hiPSC-CMs)
37%
Heart Transplantation
36%
Reperfusion
36%
Heart Failure
35%
Diabetic Cardiomyopathy
35%
Left Ventricular Ejection Fraction
33%
PRKAG2
32%
LAMP2
32%
Cardiomyocytes
31%
Induced Pluripotent Stem Cells (iPSCs)
31%
Heme oxygenase-1 (HO-1)
31%
Israel
29%
CASQ2
29%
Danon Disease
29%
Ventricular Arrhythmia
28%
Ischemia
28%
Acute Decompensated Heart Failure
27%
Antipsychotics
26%
PGC-1
26%
Duchenne muscular Dystrophy
25%
Hypertrophic Obstructive Cardiomyopathy
25%
Glycogen Storage Disease
25%
Heart Failure Patients
23%
Ca2+
23%
Clinical Outcomes
23%
Left Ventricular Function
22%
Obesity
22%
Cardiac Hypertrophy
22%
Caloric Restriction
22%
Clinical Characteristics
21%
Aficamten
20%
Calsequestrin
20%
Amyloidosis
19%
Mouse Model
19%
Glycogen
19%
Pericardial Disease
18%
Coactivator
18%
Gene mutation
18%
Sirtuin 1 (SIRT1)
17%
Left Ventricular Hypertrophy
17%
Acute Heart Failure
17%
Ventricular Pre-excitation
17%
Pharmacology, Toxicology and Pharmaceutical Science
Myocardial Disease
100%
Congestive Heart Failure
91%
Diseases
63%
Heart Arrhythmia
58%
Hypertrophic Cardiomyopathy
47%
Catecholaminergic Polymorphic Ventricular Tachycardia
42%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
35%
Diabetic Cardiomyopathy
35%
Ischemia
33%
Calcium Ion
31%
Congestive Cardiomyopathy
27%
Heart Ventricle Arrhythmia
27%
Calsequestrin
25%
Mouse Mutant
21%
Heme Oxygenase 1
20%
Hypertrophic Obstructive Cardiomyopathy
20%
Heart Ventricle Hypertrophy
18%
Cardiovascular Disease
18%
Acute Heart Failure
16%
Angiotensin
16%
Antipsychotic
16%
Mitral Valve Regurgitation
16%
Inflammation
15%
Prevalence
15%
Placebo
15%
Mouse Model
15%
Diabetes Mellitus
15%
Antiarrhythmic Drug
15%
Pericarditis
15%
Atrial Natriuretic Factor
15%
Fibrosis
14%
Danon Disease
14%
Adenosine Phosphate
14%
Obstruction
14%
Angiotensin II
14%
Receptor
13%
Heart Left Ventricle Hypertrophy
12%
Antioxidant
12%
Wolff Parkinson White Syndrome
12%
Heart Muscle Injury
11%
Phosphotransferase
11%
Recurrent Disease
11%
Heart Ventricle Tachycardia
11%
Adverse Event
10%
Mortality Rate
10%
Transgenic Mouse
10%
ATTR Amyloidosis
10%
Pyridostigmine
10%
Duchenne Muscular Dystrophy
10%
Protein Kinases
10%
Medicine and Dentistry
Myocardial Disease
94%
Congestive Heart Failure
93%
Diseases
50%
Hypertrophic Cardiomyopathy
50%
Heart Transplantation
36%
Heart Left Ventricle Ejection Fraction
29%
Dilated Cardiomyopathy
26%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
26%
Diabetes
24%
Danon Disease
23%
Prevalence
23%
Ventricular Hypertrophy
21%
Catecholaminergic Polymorphic Ventricular Tachycardia
20%
Pericarditis
20%
Hypertrophic Obstructive Cardiomyopathy
20%
Ischemia
19%
Pericardial Disorder
18%
Diabetic Cardiomyopathy
18%
Adverse Event
17%
Cardiovascular System
17%
Amyloid Protein
17%
Cardiac Dysrhythmia
17%
Recurrent Disease
16%
Acute Decompensated Heart Failure
16%
Glycogen Storage Disease
16%
Caloric Restriction
16%
Cardiology
16%
Heart Left Ventricle Function
16%
Heart Amyloidosis
16%
Ejection Fraction
15%
Mitral Insufficiency
15%
Left Ventricular Hypertrophy
15%
Oxidative Stress
15%
Peripartum Cardiomyopathy
15%
Sarcomere
15%
Cardiac Muscle Cell
15%
Obstruction
14%
Clinical Feature
13%
Cell Signaling Pathway
13%
Diabetes Mellitus
13%
Transgenic Mouse
13%
Heart Ventricle Arrhythmia
13%
New York Heart Association Class
13%
Amyloidosis
12%
Renin Angiotensin Aldosterone System
12%
ATTR Amyloidosis
12%
Quality of Life
12%
Placebo
12%
Calcium Ion
11%
Myopathy
11%
